Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models

Physiology and pharmacology of melatonin in relation to biological rhythms

(2014) Jolanta B. Zawilska et al.   Pharmacological Reports

Synthesis of Dihydrofuroaporphine Derivatives: Identification of a Potent and Selective Serotonin 5-HT1AReceptor Agonist

(2009) Zhili Liu et al.   JOURNAL OF MEDICINAL CHEMISTRY

NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats

(2009) Meihua She et al.   PHARMACOLOGICAL RESEARCH

Pathophysiology of depression: Role of sleep and the melatonergic system

(2009) Venkataramanujan Srinivasan et al.   PSYCHIATRY RESEARCH

Association of metabolic syndrome with depression and anxiety in Japanese men

(2008) T. Takeuchi et al.   DIABETES & METABOLISM

Anxiolytic-like effect of chronic treatment with Erythrina velutina extract in the elevated plus-maze test

(2008) I.M. Raupp et al.   JOURNAL OF ETHNOPHARMACOLOGY